A citation-based method for searching scientific literature

Jorge Romo-Tena, Mariana J Kaplan. Curr Opin Rheumatol 2020
Times Cited: 3







List of co-cited articles
2 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


N-acetylcysteine reduces disease activity by blocking mammalian target of rapamycin in T cells from systemic lupus erythematosus patients: a randomized, double-blind, placebo-controlled trial.
Zhi-Wei Lai, Robert Hanczko, Eduardo Bonilla, Tiffany N Caza, Brandon Clair, Adam Bartos, Gabriella Miklossy, John Jimah, Edward Doherty, Hajra Tily,[...]. Arthritis Rheum 2012
194
66

Neutrophil extracellular traps enriched in oxidized mitochondrial DNA are interferogenic and contribute to lupus-like disease.
Christian Lood, Luz P Blanco, Monica M Purmalek, Carmelo Carmona-Rivera, Suk S De Ravin, Carolyne K Smith, Harry L Malech, Jeffrey A Ledbetter, Keith B Elkon, Mariana J Kaplan. Nat Med 2016
557
66

Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis.
Richard Furie, Brad H Rovin, Frédéric Houssiau, Ana Malvar, Y K Onno Teng, Gabriel Contreras, Zahir Amoura, Xueqing Yu, Chi-Chiu Mok, Mittermayer B Santiago,[...]. N Engl J Med 2020
69
33

Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial.
Sandra V Navarra, Renato M Guzmán, Alberto E Gallacher, Stephen Hall, Roger A Levy, Renato E Jimenez, Edmund K-M Li, Mathew Thomas, Ho-Youn Kim, Manuel G León,[...]. Lancet 2011
985
33

Tacrolimus versus mycophenolate mofetil for induction therapy of lupus nephritis: a randomised controlled trial and long-term follow-up.
Chi Chiu Mok, King Yee Ying, Cheuk Wan Yim, Yui Pong Siu, Ka Hang Tong, Chi Hung To, Woon Leung Ng. Ann Rheum Dis 2016
102
33

Immunometabolism in systemic lupus erythematosus.
Laurence Morel. Nat Rev Rheumatol 2017
96
33

Clinical Efficacy and Safety of Mesenchymal Stem Cells for Systemic Lupus Erythematosus.
Tianbiao Zhou, Hong-Yan Li, Chunling Liao, Wenshan Lin, Shujun Lin. Stem Cells Int 2020
10
33

A Tale of Two Trials.
David Wofsy. Arthritis Rheumatol 2020
3
33

Short-term efficacy and safety of rituximab therapy in refractory systemic lupus erythematosus: results from the British Isles Lupus Assessment Group Biologics Register.
Eoghan M McCarthy, Emily Sutton, Stephanie Nesbit, James White, Ben Parker, David Jayne, Bridget Griffiths, David A Isenberg, Anisur Rahman, Caroline Gordon,[...]. Rheumatology (Oxford) 2018
36
33

Long-term outcome of a randomised controlled trial comparing tacrolimus with mycophenolate mofetil as induction therapy for active lupus nephritis.
Chi Chiu Mok, Ling Yin Ho, Shirley King Yee Ying, Man Chi Leung, Chi Hung To, Woon Leung Ng. Ann Rheum Dis 2020
5
33

Rituximab in systemic lupus erythematosus and lupus nephritis.
Hannah Beckwith, Liz Lightstone. Nephron Clin Pract 2014
25
33

Phase II, randomised, double-blind, multicentre study evaluating the safety and efficacy of filgotinib and lanraplenib in patients with lupus membranous nephropathy.
Matthew Baker, Yashaar Chaichian, Mark Genovese, Vimal Derebail, Panduranga Rao, Winn Chatham, Michael Bubb, Sam Lim, Hooman Hajian, Oksana Gurtovaya,[...]. RMD Open 2020
1
100

Sustained B cell depletion by CD19-targeted CAR T cells is a highly effective treatment for murine lupus.
Rita Kansal, Noah Richardson, Indira Neeli, Saleem Khawaja, Damian Chamberlain, Marium Ghani, Qurat-Ul-Ain Ghani, Louisa Balazs, Sarka Beranova-Giorgianni, Francesco Giorgianni,[...]. Sci Transl Med 2019
58
33

Multitarget therapy for induction treatment of lupus nephritis: a randomized trial.
Zhihong Liu, Haitao Zhang, Zhangsuo Liu, Changying Xing, Ping Fu, Zhaohui Ni, Jianghua Chen, Hongli Lin, Fuyou Liu, Yongcheng He,[...]. Ann Intern Med 2015
164
33

The BAFFling effects of rituximab in lupus: danger ahead?
Michael R Ehrenstein, Charlotte Wing. Nat Rev Rheumatol 2016
54
33


Current targeted therapies in lymphomas.
Clement Chung. Am J Health Syst Pharm 2019
6
33


Eradication of systemic B-cell tumors by genetically targeted human T lymphocytes co-stimulated by CD80 and interleukin-15.
Renier J Brentjens, Jean-Baptiste Latouche, Elmer Santos, Francesc Marti, Michael C Gong, Clay Lyddane, Philip D King, Steven Larson, Mark Weiss, Isabelle Rivière,[...]. Nat Med 2003
433
33

Multicenter longitudinal study of B-lymphocyte depletion in refractory systemic lupus erythematosus: the LESIMAB study.
A Fernández-Nebro, J L Marenco de la Fuente, L Carreño, M Galindo Izquierdo, E Tomero, I Rúa-Figueroa, B E Hernández-Cruz, J Narváez, E Ucar, A Olivé,[...]. Lupus 2012
63
33

Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 2 trial.
Daniel J Wallace, Richard A Furie, Yoshiya Tanaka, Kenneth C Kalunian, Marta Mosca, Michelle A Petri, Thomas Dörner, Mario H Cardiel, Ian N Bruce, Elisa Gomez,[...]. Lancet 2018
169
33

T-cell clones can be rendered specific for CD19: toward the selective augmentation of the graft-versus-B-lineage leukemia effect.
Laurence J N Cooper, Max S Topp, Lisa Marie Serrano, Sergio Gonzalez, Wen-Chung Chang, Araceli Naranjo, Christine Wright, Leslie Popplewell, Andrew Raubitschek, Stephen J Forman,[...]. Blood 2003
201
33

Clinical improvements in proliferative vs membranous lupus nephritis following B-cell depletion: pooled data from two cohorts.
Thórunn Jónsdóttir, Iva Gunnarsson, Ana Filipa Mourão, Tim Y Lu, Ronald F van Vollenhoven, David Isenberg. Rheumatology (Oxford) 2010
37
33

Calcineurin inhibitors: 40 years later, can't live without ...
Jamil R Azzi, Mohamed H Sayegh, Samir G Mallat. J Immunol 2013
128
33


2019 Update of the Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of lupus nephritis.
Antonis Fanouriakis, Myrto Kostopoulou, Kim Cheema, Hans-Joachim Anders, Martin Aringer, Ingeborg Bajema, John Boletis, Eleni Frangou, Frederic A Houssiau, Jane Hollis,[...]. Ann Rheum Dis 2020
79
33

TLR9/TLR7-triggered downregulation of BDCA2 expression on human plasmacytoid dendritic cells from healthy individuals and lupus patients.
Pingping Wu, Jiang Wu, Shuxun Liu, Xinghai Han, Jianqiang Lu, Yeqing Shi, Jianli Wang, Liwei Lu, Xuetao Cao. Clin Immunol 2008
37
33

Tofacitinib Ameliorates Murine Lupus and Its Associated Vascular Dysfunction.
Yasuko Furumoto, Carolyne K Smith, Luz Blanco, Wenpu Zhao, Stephen R Brooks, Seth G Thacker, Zarzour Abdalrahman, Giuseppe Sciumè, Wanxia L Tsai, Anna M Trier,[...]. Arthritis Rheumatol 2017
106
33

The emerging role of Janus kinase inhibitors in the treatment of autoimmune and inflammatory diseases.
William Damsky, Danielle Peterson, Julie Ramseier, Badr Al-Bawardy, Hyung Chun, Deborah Proctor, Vibeke Strand, Richard A Flavell, Brett King. J Allergy Clin Immunol 2021
10
33

Glucocorticoid withdrawal in systemic lupus erythematosus: are remission and low disease activity reliable starting points for stopping treatment? A real-life experience.
Chiara Tani, Elena Elefante, Viola Signorini, Dina Zucchi, Valentina Lorenzoni, Linda Carli, Chiara Stagnaro, Francesco Ferro, Marta Mosca. RMD Open 2019
15
33

The NET-effect of combining rituximab with belimumab in severe systemic lupus erythematosus.
Tineke Kraaij, Sylvia W A Kamerling, Esther N M de Rooij, Paul L A van Daele, Obbo W Bredewold, Jaap A Bakker, Ingeborg M Bajema, Hans U Scherer, Rene E M Toes, Tom J W Huizinga,[...]. J Autoimmun 2018
52
33

Improved Mitochondrial Metabolism and Reduced Inflammation Following Attenuation of Murine Lupus With Coenzyme Q10 Analog Idebenone.
Luz P Blanco, Hege L Pedersen, Xinghao Wang, Yaíma L Lightfoot, Nickie Seto, Carmelo Carmona-Rivera, Zu-Xi Yu, Victoria Hoffmann, Peter S T Yuen, Mariana J Kaplan. Arthritis Rheumatol 2020
15
33

Phase III, multicentre, randomised, double-blind, placebo-controlled, 104-week study of subcutaneous belimumab administered in combination with rituximab in adults with systemic lupus erythematosus (SLE): BLISS-BELIEVE study protocol.
Y K Onno Teng, Ian N Bruce, Betty Diamond, Richard A Furie, Ronald F van Vollenhoven, David Gordon, James Groark, Robert B Henderson, Mary Oldham, Paul P Tak. BMJ Open 2019
34
33

Remission in systemic lupus erythematosus: durable remission is rare.
Theresa R Wilhelm, Laurence S Magder, Michelle Petri. Ann Rheum Dis 2017
44
33

The discovery and development of belimumab: the anti-BLyS-lupus connection.
William Stohl, David M Hilbert. Nat Biotechnol 2012
83
33

Analysis of expression and function of the co-stimulatory receptor SLAMF1 in immune cells from patients with systemic lupus erythematosus (SLE).
L Liñán-Rico, B Hernández-Castro, L Doniz-Padilla, H Portillo-Salazar, L Baranda, M E Cruz-Muñoz, R González-Amaro. Lupus 2015
8
33


Expression of the markers BDCA-2 and BDCA-4 and production of interferon-alpha by plasmacytoid dendritic cells in systemic lupus erythematosus.
Stina Blomberg, Maija-Leena Eloranta, Mattias Magnusson, Gunnar V Alm, Lars Rönnblom. Arthritis Rheum 2003
104
33

Glutathione levels and sensitivity to apoptosis are regulated by changes in transaldolase expression.
K Banki, E Hutter, E Colombo, N J Gonchoroff, A Perl. J Biol Chem 1996
159
33

Sirolimus in patients with clinically active systemic lupus erythematosus resistant to, or intolerant of, conventional medications: a single-arm, open-label, phase 1/2 trial.
Zhi-Wei Lai, Ryan Kelly, Thomas Winans, Ivan Marchena, Ashwini Shadakshari, Julie Yu, Maha Dawood, Ricardo Garcia, Hajra Tily, Lisa Francis,[...]. Lancet 2018
147
33

Next-generation anti-CD20 monoclonal antibodies in autoimmune disease treatment.
Fanny Huynh Du, Elizabeth A Mills, Yang Mao-Draayer. Auto Immun Highlights 2017
68
33

Polymorphisms in the tyrosine kinase 2 and interferon regulatory factor 5 genes are associated with systemic lupus erythematosus.
Snaevar Sigurdsson, Gunnel Nordmark, Harald H H Göring, Katarina Lindroos, Ann-Christin Wiman, Gunnar Sturfelt, Andreas Jönsen, Solbritt Rantapää-Dahlqvist, Bozena Möller, Juha Kere,[...]. Am J Hum Genet 2005
435
33

Anifrolumab, an Anti-Interferon-α Receptor Monoclonal Antibody, in Moderate-to-Severe Systemic Lupus Erythematosus.
Richard Furie, Munther Khamashta, Joan T Merrill, Victoria P Werth, Kenneth Kalunian, Philip Brohawn, Gabor G Illei, Jorn Drappa, Liangwei Wang, Stephen Yoo. Arthritis Rheumatol 2017
351
33

JAK inhibitors for the treatment of autoimmune and inflammatory diseases.
Yvan Jamilloux, Thomas El Jammal, Lucine Vuitton, Mathieu Gerfaud-Valentin, Sébastien Kerever, Pascal Sève. Autoimmun Rev 2019
74
33

Therapies for mitochondrial diseases and current clinical trials.
Ayman W El-Hattab, Ana Maria Zarante, Mohammed Almannai, Fernando Scaglia. Mol Genet Metab 2017
71
33

Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: the randomized, double-blind, phase II/III systemic lupus erythematosus evaluation of rituximab trial.
Joan T Merrill, C Michael Neuwelt, Daniel J Wallace, Joseph C Shanahan, Kevin M Latinis, James C Oates, Tammy O Utset, Caroline Gordon, David A Isenberg, Hsin-Ju Hsieh,[...]. Arthritis Rheum 2010
716
33


Safety and efficacy of rituximab in systemic lupus erythematosus: results from 136 patients from the French AutoImmunity and Rituximab registry.
Benjamin Terrier, Zahir Amoura, Philippe Ravaud, Eric Hachulla, Romain Jouenne, Bernard Combe, Christine Bonnet, Patrice Cacoub, Alain Cantagrel, Michel de Bandt,[...]. Arthritis Rheum 2010
257
33

A randomized, controlled double-blind study comparing the efficacy and safety of dose-ranging voclosporin with placebo in achieving remission in patients with active lupus nephritis.
Brad H Rovin, Neil Solomons, William F Pendergraft, Mary Anne Dooley, James Tumlin, Juanita Romero-Diaz, Lidia Lysenko, Sandra V Navarra, Robert B Huizinga. Kidney Int 2019
70
33



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.